Non-structural prosthetic valve dysfunction

Article written and reviewed by Dr Luca Moretti

Non-structural dysfunction includes abnormalities of prosthetic valve function that do not result from permanent intrinsic deterioration of the leaflets or valve material. In these cases the prosthesis may be intact but positioned, expanded, sized or anchored in a way that obstructs flow, permits regurgitation or interferes with cardiac structures; it is therefore a mechanistic category, not a synonym for mild dysfunction.

It includes prosthesis-patient mismatch, paravalvular leak, malposition, underexpansion and deformation of transcatheter prostheses, interference with subvalvular structures or the outflow tract, migration and some forms of extrinsic tissue overgrowth. Many forms are recognizable immediately after implantation and remain stable; others emerge later because of dehiscence, remodeling or pannus.

This classification primarily helps avoid a common error: attributing to “wear” an elevated gradient present from the first day or regurgitation passing beside normal leaflets. Structural valve deterioration, by contrast, alters biological tissue, whereas thrombosis involves deposition of potentially reversible material and endocarditis has an infectious mechanism. Although they may coexist, these processes require distinct diagnostic and therapeutic pathways.

Diagnosis and prevention form a continuous pathway that begins before intervention with annular measurement, assessment of geometry and prediction of effective orifice area, continues in the procedure room with verification of position and any regurgitation, and is consolidated by the baseline echocardiogram. Without this sequence, an abnormality present from implantation may be interpreted years later as a new prosthetic failure.

Taxonomy and pathophysiology of non-structural forms

Prosthesis-patient mismatch occurs when the effective orifice area of a normally functioning prosthesis is too small for the flow required by the patient's body size. This produces an elevated gradient at baseline, with mobile leaflets and no new masses; severity is defined using indexed area, taking into account the necessary interpretive corrections in obesity.

Paravalvular leak is passage of blood between the prosthesis and surrounding tissue. After surgery it may result from incomplete sealing, annular calcification, tissue fragility or dehiscence, whereas after TAVI it is more often related to imperfect apposition, calcific burden, sizing or implantation depth. It may be minimal and harmless or cause heart failure and hemolysis; when newly developed or late, it should also raise suspicion of endocarditis.

Malposition is present when the prosthesis is too high, too low, tilted or not coaxial with the intended anatomy. In TAVI this may compromise sealing, hemodynamics, the coronary arteries or future access, whereas in the mitral position it may interfere with the outflow tract. A rotated surgical prosthesis or a support element conflicting with the subvalvular apparatus may also restrict an occluder despite the absence of material damage.

Underexpansion and deformation mainly affect transcatheter frames implanted in calcified anatomies, surgical rings or other prostheses. When the frame becomes elliptical, area may decrease, coaptation may be altered and leaflet stress may increase, potentially predisposing to thrombosis or later deterioration. Transition from an initial non-structural dysfunction to late structural damage is therefore a possible biological and mechanical evolution rather than a boundary between completely separate categories.

Migration and embolization are rare events that may occur early or late and whose likelihood depends on anchoring, calcification, sizing, implantation height and flow forces. If the prosthesis moves significantly, regurgitation, obstruction or coronary compromise may develop and require an urgent strategy; conversely, a modest radiographic shift without consequences should be confirmed by three-dimensional imaging before symptoms are attributed to it.

Prosthetic pannus is fibroproliferative tissue growth from the perianular tissue toward the prosthesis. Its taxonomic placement is not identical in all documents, but clinically it is an extrinsic cause of obstruction, common in mechanical valves and not reversible with anticoagulation. It may block a disc or narrow the orifice and may coexist with thrombus, resulting in an incomplete response to fibrinolysis.

Other interactions include impingement by sutures, chordal remnants, papillary muscle or native tissue, dynamic outflow tract obstruction and compromise of adjacent structures. The prosthesis may function according to its design and nevertheless alter overall physiology. Assessment therefore does not end with leaflet mobility but includes the ventricles, coronary arteries, aorta and other valves.

Hemodynamic manifestations and clinical presentation

Obstructive forms produce high gradients, reduced output and upstream overload. Symptoms include dyspnea, reduced functional capacity, angina or syncope in the aortic position and pulmonary congestion in the mitral position. Severe mismatch may prevent regression of hypertrophy after replacement; an underexpanded TAVI may initially be tolerated and become relevant when flow or ventricular function changes.

Regurgitant forms cause dilation and heart failure according to location and speed of onset. A small high-velocity leak may cause hemolysis disproportionate to regurgitant volume, whereas a large low-velocity defect causes volume overload without marked hemolysis. Fatigue, jaundice, dark urine and repeated transfusions suggest mechanical destruction of red blood cells.

Early abnormalities are often detected by imaging before symptoms develop and should be interpreted according to the expected result and their stability over time. A mild leak after TAVI, for example, may decrease as the frame progressively expands, whereas an elevated gradient due to mismatch tends to persist. If an initially stable finding worsens, a second mechanism such as thrombosis, endocarditis or degeneration should therefore be sought rather than attributing the entire progression to the original defect.

Late forms may present with heart failure, new hemolysis or changes in the murmur, and chronology, although not absolute, helps order diagnostic probabilities. A leak that appears after a period of stable sealing suggests dehiscence and makes endocarditis a priority even in the absence of fever; by contrast, pannus tends to progress slowly, whereas sudden immobility of an occluder is more compatible with thrombosis.

Laboratory assessment includes hemoglobin, reticulocytes, lactate dehydrogenase, indirect bilirubin, haptoglobin, renal function and iron status. Schistocytes support mechanical hemolysis, although they do not localize its cause, whereas fever, inflammation or dehiscence requires blood cultures. Natriuretic peptides may quantify cardiac stress but do not distinguish a leak from mismatch.

Clinical severity does not necessarily match anatomical severity, because a moderate defect may be poorly tolerated in the presence of a stiff ventricle, pulmonary hypertension or anemia, whereas a major anatomical finding may initially remain compensated. Decisions should therefore integrate symptoms, hemodynamic consequences, temporal trajectory and feasibility of correction, avoiding undue reliance on a single gradient value or circumferential percentage.

The clinical picture may also be dominated by concomitant heart disease: atrial fibrillation, coronary artery disease, right ventricular dysfunction or tricuspid regurgitation may explain a substantial proportion of symptoms. Attributing every manifestation to the prosthesis risks procedures without benefit, but ignoring prosthetic dysfunction simply because comorbidities are present creates the opposite error; a plausible pathophysiological link should therefore be demonstrated.

Echocardiography, CT and identification of the mechanism

Transthoracic echocardiography measures gradients, effective orifice area, DVI, regurgitation and chamber consequences. Comparison with baseline is central: mismatch and underexpansion produce an immediately abnormal but stable profile; thrombosis or pannus cause change. Heart rate, blood pressure, hemoglobin and stroke volume should be recorded to exclude high-flow states and nonequivalent comparisons.

When the leaflets are mobile but the gradient is high and indexed area is reduced, findings support mismatch; prolonged acceleration time, a rounded Doppler contour and limited occluder motion instead suggest acquired obstruction. Interpretation of mitral prostheses requires particular caution because the gradient depends on heart rate and pressure half-time is affected by compliance: only multiparametric analysis avoids classifying simple tachycardia as obstruction.

Three-dimensional transesophageal echocardiography allows the leak to be localized and its shape, extent, tunnel and relationships with structures and devices to be described, while also showing subvalvular interference useful for percutaneous planning. Because metallic artifacts may obscure the posterior region or simulate false discontinuities, color Doppler should be adjusted so as not to artificially enlarge the jet and severity should be integrated with venous flow and hemodynamic consequences.

Cardiac CT is superior for frame geometry, expansion, depth, relationship with coronary arteries and periprosthetic tissue. In mechanical prostheses, high-attenuation pannus is distinguished from less dense thrombus; in TAVI, eccentricity and minimum area are measured. CT may demonstrate calcification preventing sealing and help plan post-dilation, valve-in-valve or closure.

Fluoroscopy is useful for evaluating mechanical disc opening angles and frame stability, although it provides no direct tissue information; CMR, by contrast, may quantify regurgitation and volumes in selected cases. During the procedure, aortic angiography may estimate regurgitation after TAVI, whereas noninvasive imaging predominates during follow-up. The different modalities are therefore complementary and should be selected according to the specific clinical question capable of changing the decision.

In the differential diagnosis with thrombosis, anticoagulant therapy, speed of onset, presence of hypoattenuating material and response to anticoagulation are considered; if structural valve deterioration is suspected, attention instead turns to intrinsic calcification and tearing, whereas vegetations, abscesses, PET positivity and cultures suggest endocarditis. In complex cases it is often more realistic to recognize a mixed lesion than to force the findings into a single category.

The report should explicitly state the probable mechanism, location, severity and consequences. “Prosthetic regurgitation” without distinguishing intraprosthetic from paravalvular regurgitation is insufficient; “increased gradient” without flow data and comparison does not identify the cause. A useful description allows the team to choose among surveillance, drugs, post-dilation, a closure device or surgery.

Prevention and immediate post-implantation management

Surgical prevention begins with accurate annular measurement, selection of the model and expected area, and assessment of the possibility of annular enlargement. In the mitral position, the subvalvular apparatus is preserved without allowing interference; sutures and orientation are checked. Intraoperative transesophageal echocardiography assesses motion, gradients and leaks before closure, when correction is easier.

In transcatheter procedures, preprocedural CT defines the annulus, calcium distribution, access routes, relationships with the coronary arteries and outflow tract, allowing sizing to be adapted to the balance between leak and the risk of rupture or conduction disturbances. Depth, coaxiality and the need for pre-dilation or post-dilation are then tailored to the device and anatomy, while intraprocedural imaging permits timely recognition of significant regurgitation, coronary obstruction and malposition.

Post-dilation may improve apposition and increase the area of an underexpanded TAVI, but it carries risks of embolism, rupture, central regurgitation or conduction disturbances and is therefore not performed solely on the basis of an elliptical image without consequences. In selected cases, valve-in-valve or a second device may instead stabilize malposition or correct regurgitation, provided coronary access and the residual gradient have been assessed.

A relevant surgical leak recognized intraoperatively is generally corrected, especially if associated with instability or hemolysis, whereas minimal jets must first be distinguished from normal intraprosthetic phenomena. In severe annular calcification, the choice becomes more complex because the risk of damage from new suturing must be balanced against the risk of leaving the defect; team experience therefore directly influences the technical threshold for correction.

The baseline examination performed before discharge or in the following weeks documents the definitive result under stable conditions and should record manufacturer, model, size, gradients, area, regurgitation and ventricular function. This post-implantation fingerprint makes it possible to distinguish what was present from the outset from a later change and thereby makes true progression measurable.

When non-structural dysfunction is mild, stable and without consequences, surveillance and control of hemodynamic factors may be sufficient. Observation, however, is not passive: the patient is informed about warning symptoms such as dyspnea, edema, fever and signs of hemolysis, and the follow-up program defines intervals, progression parameters and conditions requiring a new procedural assessment.

Surgical or transcatheter correction and follow-up

Definitive therapy is mechanical when the defect is mechanical. Diuretics reduce congestion and iron or transfusions temporarily correct anemia, but do not close a leak or enlarge an orifice. Procedural benefit depends on the likelihood that the abnormality causes the symptoms and on the possibility of correcting it without creating a greater problem.

Surgery allows the prosthesis to be repositioned or replaced, the annulus reconstructed, pannus removed and associated disease corrected, and is particularly indicated in endocarditis, extensive dehiscence, instability, complex interference or anatomy unsuitable for catheter treatment. Redo surgery carries additional risk, but in a young patient with long life expectancy it may represent the only truly complete solution.

Transcatheter interventions include leak closure, post-dilation, valve-in-valve and retrieval or stabilization techniques and are particularly useful when surgical risk is high and anatomy is favorable. Three-dimensional planning must, however, prevent new interference: a closure device must not impede the discs of a mechanical prosthesis and a second frame must not compromise the coronary arteries. The procedure is therefore organized with the possibility of conversion also anticipated.

Hemodynamically significant pannus generally requires surgery because anticoagulation and thrombolysis do not remove fibrous tissue. If a thrombotic component coexists, a partial pharmacological response may reveal the residual obstruction; conversely, repeating fibrinolysis in the presence of a high-attenuation, slowly growing mass exposes the patient to risk without correcting the dominant mechanism.

Mismatch is primarily a problem to prevent, and reintervention is reserved for severe symptomatic cases after other causes have been excluded. When required, it may include annular enlargement, implantation of a higher-performance prosthesis or a selected transcatheter strategy, remembering that valve-in-valve in a small annulus may further reduce the area and is not an automatic solution.

After every correction, a new baseline examination should document residual leak, gradient, motion, hemolysis and ventricular response. If the technical result is not accompanied by clinical improvement, concomitant disease should be reconsidered; a residual defect requires a second intervention only when it continues to drive transfusion requirements or heart failure, not simply because it remains visible on imaging.

Prognosis depends mainly on the mechanism and how promptly it is recognized: stable mismatch may be tolerated for years, whereas migration and dehiscence may cause rapid clinical deterioration. Effective management therefore links preimplantation prevention, immediate verification of the result and serial comparison with baseline, transforming the “non-structural” category from a residual container into a mechanistic diagnosis capable of guiding a targeted solution.

A distinctive form is outflow tract obstruction after surgical or transcatheter mitral intervention. The anterior leaflet, the frame or an unfavorable aortomitral angle may narrow the systolic passage; septal hypertrophy and a small ventricle increase risk. CT simulates the neo-LVOT before the procedure, whereas Doppler measures the gradient after implantation. In high-risk cases, changes in strategy, septal treatment or controlled leaflet laceration are considered at specialized centers.

The coronary arteries, although external to the prosthesis, may also decisively determine the clinical result. A TAVI implanted too high, valve-in-valve or displaced leaflets may obstruct a coronary ostium immediately or make future coronary access difficult; ischemia, hypotension or arrhythmias after implantation therefore require urgent exclusion of this complication. Before a second valve, CT assesses coronary height, sinuses, sinotubular junction and virtual distance from the frame, allowing a coronary protection strategy to be planned when necessary.

In right-sided prostheses, conduits and transcatheter pulmonary valves, external compression and the geometry of the reconstructed tract are more important. Before some pulmonary implants, the relationship with the coronary arteries is therefore tested because they could be compressed by device expansion; in the tricuspid position, interaction with intracardiac devices and subvalvular tissue is a specific issue. The general principles of non-structural dysfunction remain valid, but aortic thresholds and left-heart pathways cannot be transferred without adaptation.

Dehiscence should be distinguished from simple malapposition because it implies failure of a previously effective anchoring system and may be accompanied by rocking motion of the prosthesis; in malapposition, by contrast, a channel is present from implantation because of incomplete contact. Late dehiscence therefore requires an aggressive search for endocarditis and assessment of annular stability, whereas focal closure may be considered only if the remaining tissue is reliable and infection has been excluded.

Hemolysis caused by interference or a residual jet should be followed with quantitative parameters, because apparently stable hemoglobin after transfusions does not demonstrate resolution of the mechanism. LDH, haptoglobin, reticulocytes, bilirubin, iron and renal function document the course; after technical correction, reduction in shear stress precedes recovery of iron stores and hemoglobin. Understanding this sequence avoids both judging a procedure ineffective too early and considering it successful while red blood cell destruction persists.

Discussion with the patient should clarify the nature of the defect and, above all, the realistically achievable result. A procedure may reduce the gradient without normalizing it or close the main leak while leaving a minimal residual defect; the expected benefit in symptoms, transfusions and hospitalizations should therefore be weighed against the risk of interference, embolization and need for a second treatment. This shared decision-making process is particularly important when available evidence comes mainly from registries and highly selected anatomies.

An internal procedural registry can ultimately link preimplantation characteristics, technique and outcome. Depth, expansion, gradients, leaks and complications are compared with later follow-up to identify device-specific patterns. This learning is essential in rapidly evolving technologies in which trials and consensus documents cannot describe every anatomical combination. Multidisciplinary review of unsuccessful cases turns an individual event into prevention for subsequent patients, provided definitions remain standardized and clinical outcomes are recorded beyond immediate procedural success.

Uniform coding is also essential to make outcomes comparable, because recording a leak as degeneration or underexpansion as thrombosis alters durability estimates and may lead to inappropriate preventive strategies. If new examinations change the presumed mechanism, classification should be updated without losing the chronology of the decision. In device medicine, terminological accuracy thus becomes an integral part not only of individual care but also of post-marketing surveillance.